Raymond James Financial
NUVB icon

Raymond James Financial’s Nuvation Bio NUVB Stock Holding History

Raymond James Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
56,621
-6,319
-10% -$30.9K ﹤0.01% 4776
2026
Q1 		$270K Buy
62,940
+2,269
+4% +$12.6K ﹤0.01% 4715
2025
Q4 		$544K Sell
60,671
-3,425
-5% -$21.2K ﹤0.01% 4214
2025
Q3 		$237K Buy
64,096
+49,677
+345% +$135K ﹤0.01% 4531
2025
Q2 		$28.1K Sell
14,419
-9,243
-39% -$19.3K ﹤0.01% 5446
2025
Q1 		$41.6K Buy
+23,662
New +$53.9K ﹤0.01% 4653

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Raymond James Financial's NUVB Position: Q2 2026 in Review

Raymond James Financial reduced its Nuvation Bio (NUVB) stake by 10% in Q2 2026, selling an estimated $30.9K and leaving 56,621 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #4776.

Raymond James Financial first reported a position in NUVB in Q1 2025 and has held it in 6 quarters since. The position peaked at $544K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Raymond James Financial held 56,621 shares of Nuvation Bio worth $322K as of Q2 2026.
  • Raymond James Financial sold 6,319 Nuvation Bio shares in Q2 2026, an estimated $30.9K.
  • Nuvation Bio made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4776 holding.
  • Raymond James Financial first reported a position in Nuvation Bio in Q1 2025 and has held it in 6 quarters since.
  • Raymond James Financial's Nuvation Bio position peaked at $544K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.